Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Pediatrix Medical Group, Inc.
Bear Case (25th pct.)
-0.5% vs price
Base Case (Median)
39.3% vs price
Bull Case (75th pct.)
88.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $37.69 | 39.3% | High (40%) |
| PE Comparable | $47.78 | 76.6% | Medium (25%) |
| Growth Trajectory DCF | $92.57 | 242.1% | Medium (20%) |
| Graham Number | $22.64 | -16.3% | Medium (40%) |
| EV/EBITDA | $31.21 | 15.3% | Medium (20%) |
| EV/FCF | $54.34 | 100.8% | Medium (20%) |
| Earnings Power Value | $3.79 | -86.0% | Medium (50%) |
Based on 7 out of 7 methods, MD appears fairly valued at the current price of $27.06. The base case fair value of $37.69 implies 39.3% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.